Regulus Therapeutics Inc. announced at the AGM held on June 10, 2013, the shareholders elected Bruce L.A. Carter, Ph.D., Mark G. Foletta, William Rastetter, Ph.D. and Douglas Williams, Ph.D as directors, each to serve until the company's 2014 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 USD | -5.97% | -9.13% | +47.66% |
05-16 | Regulus Therapeutics Inc. Announces Promotion of Rekha Garg to Chief Medical Officer | CI |
05-09 | Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.66% | 132M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- RGLS Stock
- News Regulus Therapeutics Inc.
- Regulus Therapeutics Inc. Elects Bruce L.A. Carter, Mark G. Foletta, William Rastetter and Douglas Williams as Directors